Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02310893 · ClinicalTrials.gov registry record · NA

Effectiveness of Peer Navigation and Contingency Management on Retention in HIV Care

A NA study of HIV/AIDS, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
579
Enrollment target
6
Study locations

NCT02310893 is a NA study of HIV/AIDS that has completed, run by University of California, Los Angeles. The registered enrollment target is 579 participants, below the 33,171-participant average among 61 other HIV/AIDS trials with a reported enrollment target (98% lower). The trial reports 6 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02310893, a NA study of HIV/AIDS, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
579 participants
Enrollment target
6
Study locations

Study Summary

Consistent treatment with anti-retroviral therapy (ART) suppresses viral load (VL), prolonging life and improving quality of life for HIV+ persons. Suppressing VL benefits communities by reducing transmission to others. Mere availability of ART and care, however, is insufficient; the benefits of ART depend upon HIV+ persons' continuous visits to the health care provider, regular monitoring and regular delivery of medications, - known as retention in HIV care. In spite of national efforts, up to a quarter of HIV+ persons, especially low-income minorities are out of care. Innovative interventions are therefore urgently needed to maximize engagement and retention in HIV care, self-reported adherence, as well as HIV-1 RNA viral load suppression. In pursuit of these aims, the proposed study will assess outcomes of the following interventions in comparison to usual care: 1) contingency management (CM) only; 2) peer navigation (PN) only; and 3) a combined approach that integrates both CM and PN (CA) which the investigators hypothesize to be most effective in improving HIV clinical outcomes.

Conditions Studied

HIV/AIDS

Interventions

  • BEHAVIORAL Contingency Management
  • BEHAVIORAL Peer Navigation
  • BEHAVIORAL Combined Contingency Management and Peer Navigation

Study Locations (6)

California

  • Center for Health Justice - Los Angeles
  • Los Angeles Sheriff's Department - Los Angeles
  • AltaMed Health Services Corporation - Los Angeles
  • Oasis Clinic - Los Angeles
  • Olive View Medical Center - Sylmar
  • Northeast Valley Health Corporation - Van Nuys

Trial Details

FieldValue
Enrollment Target 579 participants
Start Date 2016-01
Est. Completion 2020-01
Phase NA

Sponsor

University of California, Los Angeles

897 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02310893

The ClinicalTrials.gov registry entry for NCT02310893 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 579 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 33,171-participant average among 61 other HIV/AIDS trials with a reported enrollment target (98% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV/AIDS appearing as the primary indexed condition, and to 3 interventions - of which Contingency Management is the first listed.

NCT02310893 reports 6 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02310893 about?

NCT02310893 is a clinical study titled "Effectiveness of Peer Navigation and Contingency Management on Retention in HIV Care". Consistent treatment with anti-retroviral therapy (ART) suppresses viral load (VL), prolonging life and improving quality of life for HIV+ persons. Suppressing VL benefits communities by reducing transmission to others. Mere availability of ART and care, however, is insufficient; the benefits of ART...

What is the current status of trial NCT02310893?

This trial is currently completed. It is a NA study. The enrollment target is 579 participants. The study started on 2016-01. Estimated completion is 2020-01.

What conditions does trial NCT02310893 study?

This clinical trial studies the following conditions: HIV/AIDS.

What interventions are being tested in trial NCT02310893?

The interventions under investigation include: Contingency Management (BEHAVIORAL), Peer Navigation (BEHAVIORAL), Combined Contingency Management and Peer Navigation (BEHAVIORAL).

Who is sponsoring clinical trial NCT02310893?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02310893 being conducted?

This trial has 6 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV/AIDS

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV/AIDS

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.